PLEASANTON, Calif.--(BUSINESS WIRE)--IntegenX Inc., a privately held company that is leading the emerging field of rapid human DNA identification, today announced that Louis E. Grever, former Executive Assistant Director, Science and Technology Branch of the Federal Bureau of Investigation (FBI), has joined the company’s Board of Directors.
“Rapid DNA analysis is a transformative technology that will fundamentally change the way investigations are conducted by enabling law enforcement personnel to quickly and definitively identify suspects while they are in custody,” said Mr. Grever. “I believe this technology will create safer communities through its many applications from policing to homeland security and defense. I look forward to working with IntegenX as they introduce the first rapid DNA systems to the market this year.”
Mr. Grever recently retired from a 24-year career with the FBI. He began as a Special Agent in 1988, and was promoted to a series of positions of increasing responsibility throughout his tenure. Upon the formation of the new FBI Science and Technology Branch (STB) in 2006, Mr. Grever was assigned to the Office of the Director and served as the first Special Assistant to the STB Executive Assistant Director. In 2007, he was promoted to Deputy Assistant Director and placed in charge of the Special Technologies and Applications Office, a new entity within the STB authorized to develop and deploy innovative technical and analytical tools and capabilities for the FBI. Later in 2007, Mr. Grever was selected as the deputy to the STB Executive Assistant Director. In October 2008, he was appointed by the Director to serve as the STB Executive Assistant Director. In this role, Mr. Grever was responsible for all of the FBI’s forensic, biometric, and applied technology support to law enforcement delivered by the FBI Laboratory, Criminal Justice Information Services, and Operational Technology Divisions.
“Louis was instrumental in introducing the FBI’s Rapid DNA Initiative and in setting a vision for DNA as a fast identification tool to aid law enforcement,” said Dr. Stevan Jovanovich, Chief Executive Officer of IntegenX. “His involvement and counsel will be invaluable as we prepare to launch our RapidHIT™ 200 Human Identification System in the U.S. and globally.”
The IntegenX RapidHIT 200 is a mobile, self-contained Human Identification (HID) system that automates and accelerates the process of producing standardized DNA profiles from mouth swabs and other human samples in less than 90 minutes. Numerous local, state, national, and international law enforcement and security agencies use DNA-based human identification to make informed identification decisions regarding the arrest, detention, or release of suspects, as well as to analyze crime scene evidence. The RapidHIT 200 system will allow, for the first time, rapid DNA analysis at the point of collection — such as on arrest or detention — setting a new standard in the usage of DNA profiles as an actionable biometric similar to fingerprints.
About IntegenX Inc.
IntegenX, headquartered in Pleasanton, California, is a leading developer of rapid human DNA identification technology, DNA sequencing library preparation systems, and DNA/RNA room temperature stability and storage products. IntegenX technology platforms are the result of the integration of advanced fluidics, optics, and biochemistry capabilities to produce sample-to-answer products for DNA-based human identity testing and forensics, next generation sequencing, biodefense, and molecular diagnostics applications. The company’s expertise and intellectual property includes its patented MOVe™ valve technology, patent-pending PrepX™ reagent kits for next generation sequencing library preparation, as well as a portfolio of patented DNA and RNA reagents including GenTegra™ for stabilization and storage of purified DNA and RNA, and GenPlate® for storage of blood samples. For more information, please visit www.integenx.com.